Blood test could replace scans for predicting Lymphoma's return
NCT ID NCT06744075
Summary
This study is testing a new blood test, called a 'liquid biopsy,' to see if it can better predict whether lymphoma will come back after initial treatment. It will compare the blood test results to the standard PET-CT scan in 108 patients with B-cell or Hodgkin lymphoma. The goal is to see if tracking tiny amounts of leftover cancer DNA in the blood can help doctors make better decisions about future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, 76038, France
-
Hôpital Jacques Monod
Montivilliers, 76290, France
Conditions
Explore the condition pages connected to this study.